We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

59 hedge funds and large institutions have $178M invested in Applied Genetic Technologies Corporation in 2015 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 6

150% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 10

23% more funds holding

Funds holding: 4859 (+11)

7% less capital invested

Capital invested by funds: $191M → $178M (-$13.1M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
59
Holders Change
+11
Holders Change %
+22.92%
% of All Funds
1.57%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
17
Increased
25
Reduced
10
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$26.7M +$40.8K +1,825 +0.1%
Jennison Associates
2
Jennison Associates
New York
$20.7M -$1.01M -44,995 -4%
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$20.6M +$1.2M +53,520 +5%
VAM
4
Visium Asset Management
New York
$20M +$6.87M +307,375 +44%
EAM
5
EverPoint Asset Management
Connecticut
$10.2M
Millennium Management
6
Millennium Management
New York
$10.1M +$6.7M +299,525 +146%
PCA
7
Private Capital Advisors
Connecticut
$7.95M +$537K +24,000 +6%
PI
8
Putnam Investments
Massachusetts
$7.88M +$1.33M +59,541 +18%
PA
9
Perceptive Advisors
New York
$6.02M
SFM
10
Sphera Funds Management
Israel
$4.7M +$1.57M +70,000 +42%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$4.16M -$3.48M -155,622 -43%
EAM
12
Eventide Asset Management
Massachusetts
$4.11M
Vanguard Group
13
Vanguard Group
Pennsylvania
$3.86M +$939K +42,011 +28%
JP Morgan Chase
14
JP Morgan Chase
New York
$3.38M +$173K +7,751 +5%
BFA
15
BlackRock Fund Advisors
California
$3.27M +$175K +7,818 +5%
AGA
16
Altrinsic Global Advisors
Connecticut
$3.08M +$2.49M +111,500 +262%
SM
17
Sabby Management
Florida
$3M +$3.35M +150,000 New
GTC
18
Ghost Tree Capital
New York
$2.33M +$2.61M +116,750 New
DCM
19
DAFNA Capital Management
California
$2.19M +$2.44M +109,323 New
LOAMU
20
Lombard Odier Asset Management (USA)
New York
$1.84M +$2.06M +92,089 New
State Street
21
State Street
Massachusetts
$1.42M +$197K +8,827 +14%
Northern Trust
22
Northern Trust
Illinois
$1.19M +$48.9K +2,188 +4%
TC
23
TFS Capital
Pennsylvania
$1.11M +$1.24M +55,516 New
SGAM
24
Smith Group Asset Management
Texas
$991K +$1.11M +49,590 New
BIT
25
BlackRock Institutional Trust
California
$894K -$1.56K -70 -0.2%

AGTC Hedge Fund Activity: Q1 2015 in Review

59 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q1 2015, worth a combined $178M — down 6.9% from $191M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new AGTC positions and 6 closed out — a net gain of 11 holders — while 25 added to existing stakes and 10 trimmed.

The largest buyer was Visium Asset Management, adding an estimated $6.87M. The largest seller was T. Rowe Price Associates, cutting an estimated $3.48M.

  • 59 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q1 2015, up from 48 in Q4 2014.
  • Funds reported $178M of Applied Genetic Technologies Corporation stock for Q1 2015, down 6.9% quarter-over-quarter.
  • 17 funds opened new Applied Genetic Technologies Corporation positions in Q1 2015 and 6 closed out, a net change of +11 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q1 2015 was Visium Asset Management, an estimated $6.87M added.
  • The largest Applied Genetic Technologies Corporation seller in Q1 2015 was T. Rowe Price Associates, an estimated $3.48M sold.

Based on aggregated 13F filings for Q1 2015.